Peering Into ZyVersa Therapeutics’s Recent Short Interest
ZyVersa Therapeutics’s (NYSE:ZVSA) short percent of float has fallen 96.61% since its last report. The company recently reported…
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday’s session after the company announced that it…
What’s Going On With ZyVersa Stock?
ZyVersa Therapeutics shares are trading higher Monday after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for inhibiting ASC with IC 100 to potentially attenuate cardiac comorbidities in patients with Alzheimer's Disease.
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Shares of Aon plc (NYSE:AON) fell sharply during Friday’s session after the company reported worse-than-expected quarterly financial results.…
ZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions In Patients With Diabetes
Atherosclerosis (AS) and its sequelae are the most common cause of death in diabetic patients and one of the reasons why diabetes has entered the top 10 causes of death worldwide.The published data show that inhibiting
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Singular Genomics Sys (NASDAQ:OMIC) shares moved upwards by 17.9% to $0.66 during Friday’s after-market session. The market…
ZyVersa Therapeutics Highlights Publication Indicating That Inflammasome NLRP3-Mediated Inflammation in Obese Children Leads to Insulin Resistance and Risk of Complications Such as Type 2 Diabetes
ZyVersa Therapeutics (NASDAQ:ZVSA, or ", ZyVersa", )))), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for treatment of renal and inflammatory diseases,
ZyVersa Therapeutics Announces Peer-Reviewed Article Supporting The Therapeutic Potential Of Targeting ASC Specks During Progression Of Alzheimer’s Disease
Research demonstrated that activation of the inflammasome/ASC speck pathway has a vital role in synaptic degeneration in Alzheimer's Disease (AD).ZyVersa is developing IC 100, a monoclonal antibody targeting inflammasome
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results.
Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the consensus of $1.532 billion. Adjusted EPS of 25 cents topped the street view of 23 cents.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Celularity (NASDAQ:CELU) shares moved upwards by 44.7% to $0.27 during Thursday’s regular session. The company’s market cap…